http://lookfordiagnosis.com
English
Spanish
Italian
Portuguese
French
Swedish


Biosceptre Posts Positive Results for Basal Cell Carcinoma Drug
Biosceptre, the oncology company developing antibody products that target the nf-P2X7 receptor, announced positive results from its Phase 1 trial to assess the safety and tolerability of BIL-010t (formerly known as BSCT (Anti-nf-P2X7) 10% Ointment), ...
Drug Discovery & Development - Wed, 23 Jul 2014 08:11

Biosceptre Announces Positive Phase I Results for BIL-010t to Treat Basal Cell ...
PharmiWeb.com (press release) - Tue, 22 Jul 2014 18:07

TIPE1 induces apoptosis by negatively regulating Rac1 activation in ...
Here, we report the roles of TIPE1 in hepatocellular carcinoma (HCC). Evaluated by immunohistochemical staining, HCC tissues showed significantly downregulated TIPE1 expression compared with adjacent non-tumor tissues, which positively correlated ...
Nature.com - Mon, 21 Jul 2014 03:05

Transdermal 4-Hydroxytamoxifen Gel Beneficial in Ductal Carcinoma in Situ
MONDAY, July 21, 2014 (HealthDay News) -- For women with ductal carcinoma in situ (DCIS), 4-hydroxytamoxifen (4-OHT) gel applied to breast skin has a similar antiproliferative effect as oral tamoxifen, according to a study published in the July 15 ...
HCPLive - Mon, 21 Jul 2014 10:37

Can Sorafenib Increase Survival for Recurrent Hepatocellular Carcinoma after ...
Recurrence of hepatocellular carcinoma (HCC) remains a main detriment to long-term survival in liver transplants (LTx) for HCC. The study aims to review the use of sorafenib in recurrent HCC LTx in the Model End Stage Liver Disease era. Two hundred ...
Insurance News Net - Fri, 18 Jul 2014 08:11

The role of the dermatologist in diagnosing, managing advanced basal cell ...
Advanced basal cell carcinoma is a term whose frequency of usage has increased recently, in part, due to the introduction of the Hedgehog pathway inhibitor, vismodegib. Advanced basal cell carcinoma (aBCC) is comprised of two subtypes of BCC ...
ModernMedicine - Tue, 15 Jul 2014 20:56



New Mechanisms Leading to Treatment of Nasopharyngeal Carcinoma Identified
Nasopharyngeal carcinoma is quite an uncommon type of cancer arising from the epithelium of the nasopharynx. About half of these cancers occur in children. It is said that this type of cancer is brought about by Epstein-Barr virus (EBV) infection ...
Doctor Tipster - Wed, 16 Jul 2014 09:52



High-Risk Renal Cell Carcinoma Treatment
High-Risk Renal Cell Carcinoma Treatment. Panelists: Janice P. Dutcher, MD, Cytokine Working Group; Robert A. Figlin, MD, Cedars-Sinai; Charles A. Henderson, MD, Peachtree Consultants; Daniel Heng, MD, MPH, Calgary; Brian I. Rini, MD, Cleveland ...
OncLive - Mon, 14 Jul 2014 16:26

Angiogenic kinase inhibitor receives orphan drug designation for ...
ENMD-2076, an oral Aurora A/angiogenic kinase inhibitor has received an orphan drug designation from the Food and Drug Administration to treat hepatocellular carcinoma, according to a statement issued by the manufacturer on July 7. With that status ...
The Oncology Report - Thu, 10 Jul 2014 07:15


1  2  3  4  5  6  7  8    ->

Last update: April 2009
Statistics